Drug Discovery Today

Drug Discovery Today

今天的药物发现

  • 2区 中科院分区
  • Q1 JCR分区

期刊简介

《Drug Discovery Today》是由Elsevier Ltd出版社于1996年创办的英文国际期刊(ISSN: 1359-6446,E-ISSN: 1878-5832),该期刊长期致力于药学领域的创新研究,主要研究方向为医学-药学。作为SCIE收录期刊(JCR分区 Q1,中科院 2区),本刊采用OA未开放获取模式(OA占比0.2121...%),以发表药学领域等方向的原创性研究为核心(研究类文章占比0.00%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在239篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Drug Discovery Today审稿周期约为 约6.0个月 。该刊近年未被列入国际预警名单,年发文量约239篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 239 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
PHARMACOLOGY & PHARMACY 药学
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 23 / 354

93.6%

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q1 76 / 354

78.67%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:14.8 SJR:1.586 SNIP:1.516
学科类别 分区 排名 百分位
大类:Pharmacology, Toxicology and Pharmaceutics 小类:Pharmacology Q1 17 / 313

94%

大类:Pharmacology, Toxicology and Pharmaceutics 小类:Drug Discovery Q1 9 / 157

94%

期刊发文

  • Medicinal chemistry insights into antiviral peptidomimetics

    Author: Ding, Dang; Xu, Shujing; da Silva-Junior, Edeildo Ferreira; Liu, Xinyong; Zhan, Peng

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. 1-8. DOI: 10.1016/j.drudis.2022.103468

  • Therapeutic potential of fucosyltransferases in cancer and recent development of targeted inhibitors

    Author: Lv, Yixin; Zhang, Zhoudong; Tian, Sheng; Wang, Weipeng; Li, Huanqiu

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 1, pp. -. DOI: 10.1016/j.drudis.2022.103394

  • The transmembrane domains of GPCR dimers as targets for drug development

    Author: Cai, Xin; Wang, Dexiu; Zhang, Rumin; Chen, Yanchun; Chen, Jing

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 1, pp. -. DOI: 10.1016/j.drudis.2022.103419

  • Cordycepin and kinase inhibition in cancer

    Author: Khan, Md Asaduzzaman; Tania, Mousumi

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2022.103481

  • Intra-articular nanodrug delivery strategies for treating osteoarthritis

    Author: Zhou, Dongyang; Zhou, Fengjin; Sheng, Shihao; Wei, Yan; Chen, Xiao; Su, Jiacan

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2022.103482

  • Engineered organic nanoparticles to combat biofilms

    Author: Sheng, Yuze; Chen, Zhongjian; Wu, Wei; Lu, Yi

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 2, pp. -. DOI: 10.1016/j.drudis.2022.103455

  • Natural products in pursuing novel therapies of nonalcoholic fatty liver disease and steatohepatitis

    Author: Li, Haiyan; Guan, Ting; Qin, Shi; Xu, Qihao; Yin, Lina; Hu, Qingzhong

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2022.103471

  • Rapid progress in neuroimaging technologies fuels central nervous system translational medicine

    Author: Kong, Linghui; He, Qian; Li, Qiu; Schreiber, Rudy; Kaitin, Kenneth I.; Shao, Liming

    Journal: DRUG DISCOVERY TODAY. 2023; Vol. 28, Issue 3, pp. -. DOI: 10.1016/j.drudis.2023.103485